It is probable, therefore, that this treatment may have a dual benefit on the role of NE in the pathophysiology of emphysema and bronchiectasis in AATD by at least partly restoring an AAT/NE balance in all lung compartments. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.